Macrogenics Inc: senior vp, research & cso Ezio Bonvini exercised 8,000 shares

What happened Ezio Bonvini, senior vp, research & cso, exercised options and acquired 8,000 shares at $2.60 per share on Oct 6, 2026, for $20,800. The filing also records a derivative disposition of 8,000 shares at $2.60 for $20,800. Footnote F1 states the transaction represents an exercise and hold of options.

Key details

• Transaction date and price: Oct 6, 2026 at $2.60 per share.
• Transaction value: $20,800 for the acquired 8,000 shares (and $20,800 shown for the derivative disposition).
• Shares owned after the transaction: not reported in the provided filing details.
• Footnotes: F1 — the transaction represents an exercise and hold of options; F2 — 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% become exercisable on the first day of each 3-month period thereafter.
• Filing date: Oct 7, 2026. No late filing was indicated in the provided details.

Why it may matter

• The filing reports an options exercise. Footnote F1 indicates the shares were held after exercise (not sold cashless).
• For derivative transactions, the filing describes an exercise and hold of options per the footnote. A filing does not show why the insider traded or why the company acted.